Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Omrix initiates phase I/II clinical trial of Adhexil in gynecological surgery of the ovaries

Oct. 29, 2007

Summit initiates phase I clinical trial of SMT-D002 for seborrhea in PD

Oct. 26, 2007

Phase II omiganan study demonstrates positive results

Oct. 22, 2007

Latest findings reported for therapeutic agents under development for treatment of plaque psoriasis

Oct. 18, 2007

Novel NO donor shows potential in inflammatory skin conditions

Oct. 16, 2007

European health authorities accept marketing authorization application for alitretinoin

Oct. 15, 2007

Peplin reports interim analysis of topical gel for AK

Oct. 10, 2007

Avontec advances AVT-02 UE into the clinic for inflammatory skin diseases

Oct. 9, 2007

CardioVascular BioTherapeutics' wound healing compound successfully completes phase I

Oct. 5, 2007

Axcan licenses rights to Cx-401 for perianal fistulas

Oct. 4, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...